OpenURL Connection Search

Select item for more details and to access through your institution.

Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic.
Published in:
2022
By:
- Tontsch-Grunt, Ulrike;
- Traexler, Paula-Elena;
- Baum, Anke;
- Musa, Hanny;
- Marzin, Kristell;
- Wang, Shaonan;
- Trapani, Francesca;
- Engelhardt, Harald;
- Solca, Flavio
Publication type:
journal article
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.
Published in:
2015
By:
- Young, Natalie;
- Soneru, Christian;
- Liu, Jing;
- Grushko, Tatyana;
- Hardeman, Ashley;
- Olopade, Olufunmilayo;
- Baum, Anke;
- Solca, Flavio;
- Cohen, Ezra;
- Young, Natalie R;
- Grushko, Tatyana A;
- Olopade, Olufunmilayo I;
- Cohen, Ezra E W
Publication type:
journal article
c-Myc is required for transformation of FDC-P1 cells by EGFRvIII
Published in:
FEBS Letters, 2007, v. 581, n. 13, p. 2549, doi. 10.1016/j.febslet.2007.04.077
By:
- Rath, Oliver;
- Himmler, Adi;
- Baum, Anke;
- Sommergruber, Wolfgang;
- Beug, Hartmut;
- Metz, Thomas
Publication type:
Article
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype.
Published in:
Oncogenesis, 2018, v. 7, n. 2, p. 1, doi. 10.1038/s41389-018-0032-z
By:
- Hirt, Ulrich A.;
- Waizenegger, Irene C.;
- Schweifer, Norbert;
- Haslinger, Christian;
- Gerlach, Daniel;
- Braunger, Jürgen;
- Weyer-Czernilofsky, Ulrike;
- Stadtmüller, Heinz;
- Sapountzis, Ioannis;
- Bader, Gerd;
- Zoephel, Andreas;
- Bister, Bojan;
- Baum, Anke;
- Quant, Jens;
- Kraut, Norbert;
- Garin-Chesa, Pilar;
- Adolf, Günther R.
Publication type:
Article

Found: 4

Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic.

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.

c-Myc is required for transformation of FDC-P1 cells by EGFRvIII

Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype.